Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 2a Study of 0.05% Difluprednate Ophthalmic Emulsion in the Treatment of Anterior Uveitis (Inluding Iritis, Cyclitis, Iridocyclitis, and Panuveitis).

NCT00405496 is registered in ClinicalTrials.gov with Sirion Therapeutics, Inc. as lead sponsor.

NCT NCT00405496
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00405496 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 2a Study of 0.05% Difluprednate Ophthalmic Emulsion in the Treatment of Anterior Uveitis (Inluding Iritis, Cyclitis, Iridocyclitis, and Panuveitis).
Lead sponsor
Sirion Therapeutics, Inc.
Phase
Phase 2
Overall status
Completed
Start date
March 31, 2000
Completion date
April 30, 2001
Enrollment
24
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

anterior uveitis